DSM outlicenses coupling technology

- Last updated on GMT

Related tags: Chemistry

DSM Pharma Chemicals has licensed one of its proprietary
chemistries to US pharmaceutical specialist PharmaCore in a move
that will allow the latter firm to create new chemical building
blocks that are not available at present.

PharmaCore is licensing DSM​'s aryl nitrile based cross coupling technology. This allows a wide variety of aryl nitriles to participate in cross coupling reactions to produce derivatives useful in the manufacture of drugs and drug intermediates, including unsymmetrical biaryls, styrenes, alkylated aromatics, and alkynylated aromatics.

PharmaCore said it would immediately apply the technology toward its molecular building block business, which concentrates on using organic synthesis to create a large number of novel active pharmaceutical ingredients (APIs) and intermediates for use by drug developers.

DSM's chemistry would not only allow PhamaCore to create compounds that are not currently available elsewhere, but also makes it possible to offer compounds that would be considerably more expensive if produced via traditional means.

Joe Miller, vice president of chemistry at PharmaCore, noted that certain classes of aryl nitriles are significantly less expensive than the corresponding compounds based on aryl halides.

"This will give PharmaCore a real economic edge with respect to our competitors in the preparation of these target blocks,"​ he said.

At present, PharmaCore​'s catalogue of building blocks contains more than 1,000 different compounds.

Related news

Show more

Related products

show more

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

The Effect of Tamping Force on Bi-Layer Tablets

The Effect of Tamping Force on Bi-Layer Tablets

JRS PHARMA | 15-Aug-2020 | Technical / White Paper

Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be incompatible or maybe intended for delivery at...

Single-Pass Tangential Flow Filtration

Single-Pass Tangential Flow Filtration

BioContinuum™ Platform - MilliporeSigma | 01-Aug-2020 | Application Note

Tangential flow filtration (TFF) is widely used in the biopharmaceutical industry for downstream processing applications. Typical TFF steps concentrate...

Related suppliers

Follow us


View more